Table 1 Demographic, laboratory, and clinical data of patients

Gender

Female

187 (19.1%)

Female/ male

Male

793 (80.9%)

Age

Under 20 years old

100 (10/4%)

Numerical

21–40 years

604 (61.6%)

41–60 years

211 (21.5%)

61–80 years

60 (6.1%)

Above 81 years

5 (0.5%)

Co-ingestion

62 (6.3%)

Yes /No

Smoking

46 (4.7%)

Yes /No

Alcohol consumption

627 (64%)

Yes /No

Opium abuse

75 (7.7%)

Yes /No

Stimulants abuse

13 (1.3%)

Yes /No

History of pervious disease

150 (15.3%)

Yes /No

History of taking medication

77 (7.9%)

Yes /No

Hemoperfusion

9 (0/9%)

Yes /No

Intubation

203 (20.7%)

Yes /No

ICU admission

187 (19.1%)

Yes /No

Antidote therapy

904 (92.2%)

Yes /No

Duration of hospitalization. median (Minimum–Maximum)

2 (1–116)

Numerical

Laboratory and Clinical Data

 13 ≤ GCS < 15

659 (67.2%)

Numerical

 8 ≤ GCS < 13

62 (6.3%)

Numerical

 Coma (GCS < 8)

108 (11%)

Yes/No

 Bradypnea

46 (4.7%)

Numerical

 Temperature (Mean ± SD)

36.9 ± 0.56

Numerical

 Bradycardia

14 (1.4%)

Numerical

 Tachycardia

145 (14.8%)

Numerical

 Hypotension

38 (3.9%)

Numerical

 Hypertension

293 (29.9%)

Numerical

 Metabolic Acidosis

823 (84%)

Numerical

 Acute Kidney Injury

536 (54.7%)

Numerical

 Renal disease

641(65%)

Yes/No

 HCO₃ (Mean ± SD)

14.4 ± 23.8

Numerical

 BUN (meq/l) (Mean ± SD)

36.7 ± 27.2

Numerical

 Creatinine (meq/l) (Mean ± SD)

1.7 ± 4.1

Numerical

 Blood Glucose (mg/dl) (Mean ± SD)

132.5 ± 66.6

Numerical

 Blood PH (Mean ± SD)

7.2 ± 0.4

Numerical

 Sodium (meq/l) (Mean ± SD)

137.8 ± 10.8

Numerical

 Potassium (meq/l) (Mean ± SD)

4.7 ± 3.4

Numerical

 PCO2, PO2, HCO3, BE, Bs, WBC, Hb, Hct, PLT, AST, ALT, ALP, LDH, CPK, CPK mb, PT, PTT, INR^a

-------

Numerical

Patient Outcomes

Death

418

Yes /No

Healthy (recovery)

562

Yes /No